Gastroenterology
Volume 136, Issue 7 , Pages 2316-2324.e3, June 2009

Liver Zonation Occurs Through a β-Catenin–Dependent, c-Myc–Independent Mechanism

  • Zoé D. Burke

      Affiliations

    • Centre for Regenerative Medicine, Department of Biology & Biochemistry, University of Bath, Claverton Down, Bath, UK
  • ,
  • Karen R. Reed

      Affiliations

    • School of Biosciences, University of Cardiff, UK
  • ,
  • Toby J. Phesse

      Affiliations

    • School of Biosciences, University of Cardiff, UK
  • ,
  • Owen J. Sansom

      Affiliations

    • The Beatson Institute, Garscube Estate, Glasgow, UK
  • ,
  • Alan R. Clarke

      Affiliations

    • School of Biosciences, University of Cardiff, UK
    • Corresponding Author InformationAlan Clarke, School of Biosciences, University of Cardiff, Cardiff CFIO 3AX, United Kingdom. fax: (44) 1225 386779
  • ,
  • David Tosh

      Affiliations

    • Centre for Regenerative Medicine, Department of Biology & Biochemistry, University of Bath, Claverton Down, Bath, UK
    • Corresponding Author InformationReprint requests Address requests for reprints to: David Tosh, Centre for Regenerative Medicine, Department of Biology & Biochemistry, University of Bath, Claverton Down, Bath BA2 7AY, United Kingdom. fax: (+44) 1225 386779

Received 10 June 2008; accepted 26 February 2009. published online 06 March 2009.

Background and Aims

The Wnt pathway has previously been shown to play a role in hepatic zonation. Herein, we have explored the role of 3 key components (Apc, β-catenin, and c-Myc) of the Wnt pathway in the zonation of ammonia metabolizing enzymes.

Methods

Conditional deletion of Apc, β-catenin, and c-Myc was induced in the livers of mice and the expression of periportal and perivenous hepatocyte markers was determined by polymerase chain reaction, Western blotting, and immunohistochemical techniques.

Results

Under normal circumstances, the urea cycle enzyme carbamoylphosphate synthetase I (CPS I) is present in the periportal, intermediate, and the first few layers of the perivenous zone. In contrast, glutamine synthetase (GS)—and nuclear β-catenin—is expressed in a complementary fashion in the last 1–2 cell layers of the perivenous zone. Conditional loss of Apc resulted in the expression of nuclear β-catenin and GS in most hepatocytes irrespective of zone. Induction of GS in hepatocytes outside the normal perivenous zone was accompanied by a reduction in the expression of CPS I. Deletion of β-catenin induces a loss of GS and a complementary increase in expression of CPS I irrespective of whether Apc is present. Remarkably, deletion of c-Myc did not perturb the pattern of zonation.

Conclusions

It has been shown that the Wnt pathway is key to imposing the pattern of zonation within the liver. Herein we have addressed the relevance of 3 major Wnt pathway components and show critically that the zonation is c-Myc independent but β-catenin dependent.

Abbreviations used in this paper: Apc, adenomatous polyposis coli, bNF, β-napthoflavone, CPS I, carbamoylphosphate synthetase I, Dkk1, Dickkopf-1, GAPDH, glyceraldehyde-3-phosphate dehydrogenase, GS, glutamine synthetase, Ihh, Indian hedgehog, LRP, low-density lipoprotein-related protein receptor, PEPCK, phosphoenolpyruvate carboxykinase, PFK, 6-phosphofructo-2-kinase, RT-PCR, reverse transcriptase polymerase chain reaction, Rrm2, ribonucleotide reductase

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Conflicts of interest The authors disclose no conflicts.

 Funding Supported by the Wellcome Trust and Cancer Research UK.

PII: S0016-5085(09)00349-7

doi:10.1053/j.gastro.2009.02.063

Gastroenterology
Volume 136, Issue 7 , Pages 2316-2324.e3, June 2009